Antonio
Pineda Lucena
Investigador Senior
Instituto de Biomedicina de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (9)
2017
-
The PipX Protein, When Not Bound to Its Targets, Has Its Signaling C-Terminal Helix in a Flexed Conformation
Biochemistry, Vol. 56, Núm. 25, pp. 3211-3224
2014
2011
-
Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain
Apoptosis, Vol. 16, Núm. 5, pp. 460-467
-
Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1
Human Molecular Genetics, Vol. 20, Núm. 18, pp. 3545-3553
-
NMR structure and dynamics of recombinant wild type and mutated jerdostatin, a selective inhibitor of integrin α 1β 1
Proteins: Structure, Function and Bioinformatics, Vol. 79, Núm. 8, pp. 2530-2542
2009
-
Deciphering the antitumoral activity of quinacrine: Binding to and inhibition of Bcl-xL
Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 6, pp. 1592-1595
2008
-
Design of a bivalent peptide with two independent elements of secondary structure able to fold autonomously
Journal of Peptide Science, Vol. 14, Núm. 7, pp. 845-854
-
Solvent-exposed residues located in the β-sheet modulate the stability of the tetramerization domain of p53-A structural and combinatorial approach
Proteins: Structure, Function and Genetics, Vol. 71, Núm. 4, pp. 1670-1685
2006
-
Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A
Journal of Biological Chemistry, Vol. 281, Núm. 47, pp. 35942-35953